MXCT
MaxCyte, Inc. · Healthcare
Director Stanley C Erck sold $177K of MaxCyte, Inc.
Sold$177,403
$3.72Price
47,689Shares
−15%Stake
What MXCT did after the filing
- The stock from Tue, Nov 5 close, $3.86
- +8.5%
- S&P 500, same days
- +1.7%
Measured over 30 trading days, to the Dec 18 close.
Traded Fri, Nov 1. Filed Tue, Nov 5, 11:25 AM ET, during the session. Returns use the Nov 5 close and the Dec 18 close. Not investment advice.